BDMD (Baird Medical Corp) רווחיות מכירות לפי רווח גולמי

Baird Medical Investment (BDMD) partners with clinics to implement minimally invasive removal of neoplasms. The change in gross profit margin demonstrates the financial dynamics of the Chinese manufacturer of microwave ablation systems, a leader in the thyroid therapy segment. The 85.60 mark reflects fresh data, confirming the potential of the R&D division, which is currently actively preparing breakthrough therapeutic devices for a global launch.
פילוחי מדדים מקיפים ואנליטיקה עבור Baird Medical Corp (BDMD)

Gross margin is calculated as the portion of revenue minus direct production costs, reflecting fundamental efficiency in cost management and the product's pricing power. For Baird Medical Investment (BDMD), this metric demonstrates the extent to which the automation of Chinese plants and chip inventories offset cost inflation, allowing for an assessment of the business's operational resilience via the aggregate gross margin.